Financial Results : Al-Razi 2025 profit surges to SAR 819,000; H2 at SAR 703,000

Al-Razi 2025 profit surges to SAR 819,000; H2 at SAR 703,000

31/03/2026 Argaam Exclusive

View other reports

Al-Razi Medical Co. reported a net profit surge to SAR 819,000 in 2025, compared to SAR 176,000 a year earlier due to increased sales along with lower operating expenses.


Financials (M)

Item 2024 2025 Change‬
Revenues 61.35 74.38 21.2 %
Gross Income 16.59 19.30 16.3 %
Operating Income 0.43 1.57 262.2 %
Net Income 0.18 0.82 365.9 %
Average Shares 1.52 1.52 -
Earnings Per Share before unusual items (Riyals) 0.12 0.54 365.9 %
EPS (Riyal) 0.12 0.54 365.9 %

The company’s H2 2025 net profit soared to SAR 703,000, compared with SAR 170,000 in H2 2024, and SAR 120,000 in H1 2025.

 


Current Half Annual Comparison (M)

Compared With The
Item H2 2024 H2 2025 Change‬
Revenues 30.15 40.40 34.0 %
Gross Income 8.40 10.20 21.4 %
Operating Income 0.21 0.97 370.6 %
Net Income 0.17 0.70 324.6 %
Average Shares 1.52 1.52 -
Earnings Per Share before unusual items (Riyal) 0.11 0.46 324.6 %
EPS (Riyal) 0.11 0.46 324.6 %
Total shareholders’ equity, with no minority interest, amounted to SAR 23.50 million as of Dec. 31, 2025, compared to SAR 22.62 million in the year-earlier period.
 
Attached document:
 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.